logo
Ringgit opens flat against US dollar, higher versus other majors

Ringgit opens flat against US dollar, higher versus other majors

The Sun5 days ago
KUALA LUMPUR: The ringgit opened flat against the US dollar but rose against other major currencies, with investors still weighing the outcome of the Federal Open Market Committee (FOMC) meeting and Washington's reciprocal tariff measures, which take effect today.
At 8 am, the local note stood at 4.2650/2850 against the US dollar, almost unchanged from Thursday's close of 4.2650/2730.
Bank Muamalat Malaysia Bhd chief economist Dr Mohd Afzanizam Abdul Rashid told Bernama that the newly announced tariff will likely support the ringgit and lift investor sentiment.
Earlier, the United States announced a reduced tariff of 19 per cent on Malaysian imports, effective Aug 1, 2025.
On July 7, US President Donald Trump said Washington would impose a 25 per cent tariff on all Malaysian products entering the country, separate from existing sectoral tariffs. The new rate, effective today, is one percentage point higher than the 24 per cent announced in April.
Mohd Afzanizam noted that the US Dollar Index (DXY) continued to rise, gaining 0.15 per cent to reach 99.968 points, supported by the tariff decision and a stronger-than-expected Personal Consumption Expenditures (PCE) price index, which climbed to 2.6 per cent in June.
He said the data suggested inflationary risks remained and could prompt the Federal Reserve (Fed) to keep the Fed Funds Rate unchanged at its September meeting.
'Against such a backdrop, the ringgit is expected to stay soft, possibly around RM4.26. Yesterday, the ringgit weakened by 0.61 per cent to close at RM4.2690.
'It appears that, following the FOMC meeting, the US dollar gained traction as the Fed remains committed to its restrictive policy stance to contain inflation risks,' he added.
At the opening, the ringgit was higher against other major currencies.
It strengthened against the Japanese yen to 2.8277/8411 from 2.8443/8498 on Thursday, rose against the British pound to 5.6328/6592 from 5.6426/6532, and gained against the euro to 4.8711/8939 from 4.8766/8857.
The ringgit was mixed against regional peers.
It was little changed against the Philippine peso at 7.31/7.35 from 7.31/7.33 and flat against the Indonesian rupiah at 259.1/260.5 from 259.1/259.7.
The local note rose against the Thai baht to 13.0169/0876 from 13.0448/0753 and strengthened versus the Singapore dollar to 3.2856/3012 from 3.2889/2953. - Bernama
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tariffs unlikely to shake domestic industries
Tariffs unlikely to shake domestic industries

The Star

time34 minutes ago

  • The Star

Tariffs unlikely to shake domestic industries

PETALING JAYA: Domestically-driven sectors and ones that depend mostly on internal demand will likely be able to sustain their earnings despite volatilities of trade and impending tariffs. Areca Capital Sdn Bhd chief executive officer Danny Wong said such sectors including banks, data centre-related companies and those dealing with construction, utilities and even land sales, will fare better. 'These sectors could likely outperform the ones that are affected by external factors like tariffs. 'These may settle down once tariffs are finalised or when news of it becomes stale eventually,' he told StarBiz. In early April, the Trump administration implemented an initial 24% tariff on Malaysian goods, but faced threats of a 25% rate with potential hikes of up to 40%. After intense negotiations, a trade pact was agreed, cutting the effective US tariff on Malaysian goods to 19 % – effective this month. For now, semiconductors that fall under Section 232 and pharmaceuticals remain exempt. Wong said for the technology sector, some companies will be able to pivot quickly in light of any new development coming from tariffs. 'It will solely depend on the sub sector and the companies whether they are chip makers, artificial intelligence, or automotive for example. 'But companies that depend on resources like labour might find it challenging,' he explained. Analysts also believe the aforementioned sectors will be able to counter external headwinds. For instance, Maybank Investment Bank (Maybank IB) Research stated that it expects a more balanced second quarter after a rather underwhelming first quarter of 2025. It noted sectors such as construction, healthcare, property and, more selectively, the oil and gas and utilities sectors will have positive momentum. However, planters may see weaker earnings in the second quarter from lower crude palm oil prices, while others might see an uplift from the currency exchange and disposal gains. Meanwhile, Hong Leong Investment Bank Research (HLIB Research) said in a recent report that despite so many uncertainties, not all is doom and gloom. According to the research house, Malaysia still has many factors that will support overall national competitiveness. 'Exemptions remain in place, reflecting the United States recognition that it cannot afford to alienate Malaysia, given its strategic role in the global supply chain. 'Malaysia accounts for approximately 19.8% of total US semiconductor imports, followed closely by Chinese Taipei at 19% and Vietnam at 10%. 'Malaysia's electrical and electronics exports account for 70% of total exports to the United States,' the report said. Furthermore, Malaysia's trade performance had also improved, driven by resilient export growth, greater market diversification, and a recovery in the tourism sector. In addition to that, the country's extensive network of bilateral free trade agreements and participation in the Regional Comprehensive Economic Partnership alongside trade talks will bring about opportunities for preferential market access, thus positioning Malaysia as a regional trade hub. CIMB Securities looked at the manufacturing sector, and noted that in 2024, Malaysia held the largest share of the rubber glove market. 'We expect some incremental shift in US glove orders to Malaysia, but higher tariffs will still increase US buyers' cost base, which may limit restocking or lead to leaner inventories,' it said. The research house added China and Vietnam will most likely redirect supply to non-US markets at a more competitive average selling price (ASP), further intensifying global pricing pressure. 'We believe the revised US tariff rates for glove-producing countries will prompt Chinese glove makers to shift production to the Asean region, particularly Indonesia, to benefit from lower US tariffs,' CIMB Securities said. It added that it will maintain a 'neutral' stance on the sector on the back of ongoing headwinds, particularly sluggish demand recovery due to cautious buyer purchasing patterns, elevated costs and weak ASPs in an oversupplied market with new incoming capacity, particularly from Indonesia. Maybank IB agreed, stating that even though Malaysia enjoys a lower tariff rate of 19%, the narrow or zero tariff differential against regional peers such as Indonesia, Thailand and Vietnam provides limited competitive advantage for Malaysian glove makers, especially as China glove makers continue to expand capacity in these countries. It noted that these offshore facilities allow China players to bypass US tariffs on China-origin goods, further intensifying competition within South-East Asia and limiting pricing power. 'Our channel checks indicate China production costs overseas range from US$14 to US$15 per 1,000 pieces versus Malaysia's US$15 to US$16 per 1,000 pieces. 'With similar tariffs and higher costs, local glove makers have limited pricing power and could risk losing US market share once the new capacity in these countries comes online by end-2025 to early-2026,' it said. With that, Maybank IB said it will maintain a 'negative' stance on local glovemakers with lower target prices as well. 'We believe upcoming results could be weak, mainly due to the weakening US dollar versus the ringgit,' it noted. It also said cost efficiency will be key in maintaining competitiveness.

China turns to BRICS partner for coffee
China turns to BRICS partner for coffee

Malaysia Sun

time2 hours ago

  • Malaysia Sun

China turns to BRICS partner for coffee

Beijing fast-tracked authorization for nearly 200 Brazilian firms after the US slapped massive tariffs on the countrys products Beijing has authorized nearly 200 Brazilian companies to export coffee to the Chinese market amid escalating trade tensions between the South American nation and the US, according to the Chinese embassy in Brazil. The greenlight follows Washington's decision to impose a hefty tariff on Brazilian coffee and other goods. The 50% tariff, which took effect in late July, targets coffee and meat - two key sectors of Brazil's economy. The move comes amid the broader trade war launched by US President Donald Trump against multiple countries. "China has approved the authorization of 183 new Brazilian coffee companies to export to the Chinese market," the embassy said Saturday in a post, adding that the measure took effect on July 30 and will remain valid for five years. Brazil's Ministry of Industry and Foreign Trade has estimated that 35.9% of exports to the US will be affected by the tariffs, warning that annual losses could reach up to $14.5 billion. During the 2024/2025 crop year, Brazil exported 7.468 million bags of coffee to the US, making it the largest destination for Brazilian coffee exports, according to the Brazilian Coffee Exporters Council. The US accounted for 16.4% of Brazil's total coffee exports. In monetary terms, that amounted to $1.9 billion in coffee exports, along with $1.35 billion worth of meat. READ MORE: The BRICS hit back: Trumps old tricks meet new world China's growing appetite for coffee appears to align with its latest move to expand imports from Brazil. According to data from the International Coffee Organization, coffee consumption in China grew by 15% in the latest season. At the same time, the number of branded coffee shops in the country surged by 58% over the past 12 months, reaching 49,691 outlets, according to market intelligence firm Alegra Group. The rapid expansion signals China's emergence as a key growth market for global coffee producers. Trump has defended the steep tariffs on Brazilian goods, citing what he called a "witch hunt" against former President Jair Bolsonaro, despite the fact that the US ran a $6.8 billion trade surplus with Brazil in 2024. Trump had previously justified his trade policies by claims that he intended to correct trade imbalances. (

Pfizer reports strong Q2 revenue
Pfizer reports strong Q2 revenue

The Star

time2 hours ago

  • The Star

Pfizer reports strong Q2 revenue

NEW YORK, Aug. 5 (Xinhua) -- U.S. pharmaceutical company Pfizer announced its second-quarter earnings on Tuesday, reporting a 10 percent year over year operational growth. The financial results posted by the New York-headquartered company represent revenue of 14.7 billion U.S. dollars or 0.51 dollars of earnings per share. In an upward revision of its full-year guidance, Pfizer said it now expects adjusted earnings per share for 2025 to range between 2.90 dollars and 3.10 dollars, compared to its previous forecast of 2.80 dollars to 3.00 dollars. The company maintained its annual revenue projection of 61 billion to 64 billion dollars, reflecting confidence in its underlying business performance. "Our business is performing well and I'm pleased with the progress we achieved in the second quarter," Pfizer Chairman and CEO Albert Bourla said in a statement. Pfizer's strong performance came amid mounting policy pressures from the White House. U.S. President Donald Trump has recently sent letters to 17 pharmaceutical companies, including Pfizer, demanding that they cut prices on all existing medications for Medicaid patients to levels no higher than those in Europe. During Tuesday's earnings call, Bourla acknowledged that the company received the letter from the Trump administration. However, he declined to elaborate on the policy's specific impacts, although he emphasized that discussions with the administration have been "extremely productive." Pfizer's Q2 results were bolstered by rising sales in several key product categories. Its Vyndaqel line of cardiomyopathy treatments showed solid growth, and COVID-19-related products were major contributors.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store